PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 1 filers reported holding PROVENTION BIO INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $41,753,395 | +26.8% | 1,732,506 | -44.4% | 0.00% | +100.0% |
| Q4 2022 | $32,941,152 | +465.5% | 3,116,476 | +140.8% | 0.00% | – |
| Q3 2022 | $5,825,000 | +20.4% | 1,294,425 | +7.0% | 0.00% | – |
| Q2 2022 | $4,837,000 | -48.2% | 1,209,189 | -5.1% | 0.00% | – |
| Q1 2022 | $9,331,000 | +36.9% | 1,274,666 | +5.1% | 0.00% | – |
| Q4 2021 | $6,815,000 | -25.3% | 1,212,710 | -14.9% | 0.00% | – |
| Q3 2021 | $9,125,000 | -18.5% | 1,425,738 | +7.3% | 0.00% | -100.0% |
| Q2 2021 | $11,198,000 | -1.7% | 1,328,337 | +22.4% | 0.00% | 0.0% |
| Q1 2021 | $11,393,000 | -32.5% | 1,085,609 | +9.0% | 0.00% | 0.0% |
| Q4 2020 | $16,872,000 | +27.3% | 995,965 | -3.6% | 0.00% | 0.0% |
| Q3 2020 | $13,256,000 | +8.5% | 1,033,239 | +19.4% | 0.00% | 0.0% |
| Q2 2020 | $12,214,000 | +6839.8% | 865,599 | +4431.9% | 0.00% | – |
| Q1 2020 | $176,000 | -48.1% | 19,100 | -16.0% | 0.00% | – |
| Q4 2019 | $339,000 | +189.7% | 22,730 | +32.9% | 0.00% | – |
| Q3 2019 | $117,000 | – | 17,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 6,000,000 | $43,920,000 | 2.10% |
| VR Adviser, LLC | 1,118,653 | $8,189,000 | 1.33% |
| DG Capital Management, LLC | 522,568 | $3,825,000 | 0.77% |
| Atom Investors LP | 42,680 | $312,000 | 0.15% |
| ADVISORY RESEARCH INC | 235,000 | $1,720,000 | 0.14% |
| Perceptive Advisors | 791,549 | $5,794,000 | 0.12% |
| Verition Fund Management LLC | 1,086,593 | $7,954,000 | 0.10% |
| Virtus ETF Advisers LLC | 26,467 | $194,000 | 0.09% |
| 1900 WEALTH MANAGEMENT LLC | 95,555 | $699,000 | 0.07% |
| RICE HALL JAMES & ASSOCIATES, LLC | 220,065 | $1,611,000 | 0.06% |